LLY

1,081.58

-1.94%↓

JNJ

224

-0.52%↓

ABBV

213.26

-2.16%↓

UNH

378.3

-0.09%↓

MRK

115.22

-2.85%↓

LLY

1,081.58

-1.94%↓

JNJ

224

-0.52%↓

ABBV

213.26

-2.16%↓

UNH

378.3

-0.09%↓

MRK

115.22

-2.85%↓

LLY

1,081.58

-1.94%↓

JNJ

224

-0.52%↓

ABBV

213.26

-2.16%↓

UNH

378.3

-0.09%↓

MRK

115.22

-2.85%↓

LLY

1,081.58

-1.94%↓

JNJ

224

-0.52%↓

ABBV

213.26

-2.16%↓

UNH

378.3

-0.09%↓

MRK

115.22

-2.85%↓

LLY

1,081.58

-1.94%↓

JNJ

224

-0.52%↓

ABBV

213.26

-2.16%↓

UNH

378.3

-0.09%↓

MRK

115.22

-2.85%↓

Home・Stock List・Medpace Holdings Inc

Medpace Holdings Inc

Open

SectorHealthcare

453.86 1.49

Buy Sell

Overview

Share price change

24h

Current

Min

439.69

Max

460.33

Key metrics
By Trading Economics
Income	-11M 124M
Sales	-1.8M 707M
P/E Sector Avg	26.908 50.102
EPS	4.28
Profit margin	17.53
Employees	6,300
EBITDA	-16M 148M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+0.09% upside

Dividends
By Dow Jones
Next Earnings	20 Jul 2026

Market Stats
By TradingEconomics
Market Cap	-2.9B 12B
Previous open	452.37
Previous close	453.86

News Sentiment

By Acuity

76%

24%

301 / 344 Healthcare

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Oct 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

0.09% upside

12 Months Forecast

Average 447.5 USD 0.09%

High 495 USD

Low 393 USD

Based on 8 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Medpace Holdings Inc - Dist in the past 3 months.

Sentiment

By Acuity

301 / 344 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.